Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-21

Clinical Trial Update: APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/Phase 2 study of APIC-CF Therapy for mild to moderate osteoarthritis of the knee. The current trial status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APIC-CF Therapy

Snippet

Sponsor: Cytonics Corporation | Conditions: Pain, Osteoarthritis | Phase 1, Phase 2 | Status: UNKNOWN